kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the AVIR dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for AVIR.

AVIR

Atea Pharmaceuticals, Inc.
Pharmaceuticals · Pharmaceuticals
$95.56 sample
+0.68 (+0.72%) 1D
☆ Watch
Market cap
$214.2B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-13
Alerts
8
Price$95.56 -0.19% 3M daily closessample
99.3188.26
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 22INSInsider buy: Chief Financial Officer
  • Oct 13SECForm 144 filed
  • Oct 06INSInsider sell: Chief Financial Officer
  • Sep 25INSInsider sell: 10% owner
  • Sep 17INSInsider buy: Chief Financial Officer
  • Sep 11INSInsider buy: 10% owner
  • Sep 03INSInsider sell: 10% owner
  • Aug 26INSInsider buy: 10% owner
Sign up to see the real AVIR record →

Company facts

SEC EDGAR registration
Name
Atea Pharmaceuticals, Inc.
Sector
Pharmaceuticals
Industry
Pharmaceuticals
Smart-money score
+59sample, -100 to +100
Reporting currency
USD

Who is positioning in AVIR

sample
Insiders
35 insider transactions over 90 days, net selling, $501.7M
Congress
5 members traded over 90 days
Institutions · 13F
31 funds hold $2.7B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$5.7B +19.5% y/y
Q4 2024Q3 2026
Inventory$3.3B +12.2% y/y
Q4 2024Q3 2026
Accounts receivable$2.6B +11.7% y/y
Q4 2024Q3 2026
Total debt$6.9B +20.2% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$92.9B -10.9% 3M
Sample peer B
$126.0B +12.3% 3M
Sample peer C
$29.4B -8.0% 3M
Sample peer D
$194.7B +16.0% 3M
Sample peer E
$65.3B -9.3% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not AVIR's real figure. Nothing here is investment advice.